Latest filing published 01 Jun 2026 for Edesa Biotech, Inc..
All filings by Sean A. MacDonald on record concern Edesa Biotech, Inc. Between 11 October 2023 and 27 May 2026, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 1 June 2026 came the latest disclosure, a share grant in Edesa Biotech, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration